Not available
Quote | Harvard Bioscience Inc. (NASDAQ:HBIO)
Last: | $3.13 |
---|---|
Change Percent: | 1.3% |
Open: | $3.04 |
Close: | $3.13 |
High: | $3.25 |
Low: | $2.9901 |
Volume: | 200,826 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Harvard Bioscience Inc. (NASDAQ:HBIO)
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...
HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriot...
Message Board Posts | Harvard Bioscience Inc. (NASDAQ:HBIO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $HBIO News Article - Harvard Bioscience Announces First Quarter 2023 Financial Results | whytestocks | investorshangout | 04/25/2023 2:25:47 PM |
whytestocks: $HBIO News Article - Harvard Bioscience to Present at KeyBanc Capital Markets Life Scie | whytestocks | investorshangout | 03/16/2023 7:05:50 PM |
whytestocks: $HBIO News Article - Harvard Bioscience Announces Fourth Quarter 2022 Financial Results | whytestocks | investorshangout | 03/09/2023 4:05:47 PM |
whytestocks: $HBIO News Article - Harvard Bioscience Announces Fourth Quarter 2021 Financial Results | whytestocks | investorshangout | 03/08/2022 7:00:51 PM |
whytestocks: $HBIO News Article - Harvard Bioscience Announces Third Quarter 2021 Financial Results | whytestocks | investorshangout | 11/03/2021 6:50:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Harvard Bioscience Inc. Company Name:
HBIO Stock Symbol:
NASDAQ Market:
Harvard Bioscience Inc. Website:
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...
HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriot...
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22 ...